Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth

Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth

Submitted by admin on January 25, 2023 - 10:30am
Source: 
Investors Business Daily
News Tags: 
Abbott Labs
earnings
diagnostics
COVID-19
Headline: 
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
snippet: 

Early Wednesday, Abbott Laboratories (ABT) announced adjusted profit of $1.03 per share on $10.09 billion in fourth-quarter sales. In response, ABT stock fell.

Do Not Allow Advertisers to Use My Personal information